CasInvent
CasInvent Pharma develops new therapeutic options for the treatment of selected malignancies.
Total raised
€1.3M
€1,300,000
Funding rounds
1
Investors
2
distinct backers
Active since
2022-09
latest 2022-09
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood22
base rate 30% for Other
- ▼ Overdue vs cohort gap
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-09-27 | Other | €1.3M | i&i Biotech Fund,KHAN Technology Transfer Fund I | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Oura Health€779MFinland · Healthtech
- Doctolib€734MFrance · E-commerce